HK1011973A1 - Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-n-oxides process for their preparation and their use as medicaments - Google Patents
Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-n-oxides process for their preparation and their use as medicamentsInfo
- Publication number
- HK1011973A1 HK1011973A1 HK98113073A HK98113073A HK1011973A1 HK 1011973 A1 HK1011973 A1 HK 1011973A1 HK 98113073 A HK98113073 A HK 98113073A HK 98113073 A HK98113073 A HK 98113073A HK 1011973 A1 HK1011973 A1 HK 1011973A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- alkyl
- pyridine
- bond
- opt
- sic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4410480A DE4410480A1 (de) | 1994-03-25 | 1994-03-25 | Sulfonamidocarbonylpyridin-2-carbonsäureesteramide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1011973A1 true HK1011973A1 (en) | 1999-07-23 |
Family
ID=6513896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98113073A HK1011973A1 (en) | 1994-03-25 | 1998-12-10 | Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-n-oxides process for their preparation and their use as medicaments |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5620996A (ko) |
| EP (1) | EP0673932B1 (ko) |
| JP (1) | JPH07278110A (ko) |
| KR (1) | KR950032126A (ko) |
| AT (1) | ATE193702T1 (ko) |
| AU (1) | AU688450B2 (ko) |
| CA (1) | CA2145475A1 (ko) |
| CZ (1) | CZ289536B6 (ko) |
| DE (2) | DE4410480A1 (ko) |
| DK (1) | DK0673932T3 (ko) |
| ES (1) | ES2146676T3 (ko) |
| FI (1) | FI951387A (ko) |
| GR (1) | GR3033706T3 (ko) |
| HK (1) | HK1011973A1 (ko) |
| HU (1) | HUT72598A (ko) |
| NO (1) | NO304265B1 (ko) |
| NZ (1) | NZ270784A (ko) |
| PL (1) | PL180678B1 (ko) |
| PT (1) | PT673932E (ko) |
| ZA (1) | ZA952409B (ko) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE256113T1 (de) * | 1996-03-21 | 2003-12-15 | Lonza Ag | Verfahren zur herstellung von arylamiden heteroaromatischer carbonsäuren |
| SK283920B6 (sk) | 1996-03-28 | 2004-05-04 | Lonza Ag | Spôsob výroby arylamidov heteroaromatických karboxylových kyselín |
| DK0806415T3 (da) * | 1996-05-09 | 2000-06-05 | Lonza Ag | Fremgangsmåde til fremstilling af arylamider af heteroaromatiske carboxylsyrer |
| US6169183B1 (en) | 1996-07-23 | 2001-01-02 | Lonza, Ltd. | Process for preparing pyridinecarboxylic esters |
| CA2209392C (en) * | 1996-07-23 | 2007-02-20 | Yves Bessard | Process for preparing pyridinecarboxylic esters |
| DE19742951A1 (de) | 1997-09-29 | 1999-04-15 | Hoechst Schering Agrevo Gmbh | Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung |
| EP2295060B1 (en) | 2001-12-06 | 2018-10-31 | Fibrogen, Inc. | Treatment or prevention of ischemic or hypoxic conditions |
| US20030153503A1 (en) | 2001-12-06 | 2003-08-14 | Klaus Stephen J. | Methods of increasing endogenous erythropoietin (EPO) |
| US7618940B2 (en) * | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
| US8124582B2 (en) | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| EP1491527A1 (en) * | 2003-06-25 | 2004-12-29 | Bayer CropScience GmbH | Process for preparing acylsulfamoylbenzamides |
| KR20080028918A (ko) | 2005-06-15 | 2008-04-02 | 피브로겐, 인크. | 암의 치료를 위한 화합물과 방법 |
| EP2008461B1 (en) * | 2006-03-30 | 2015-09-16 | LG Electronics Inc. | A method and apparatus for decoding/encoding a multi-view video signal |
| ES2705587T3 (es) | 2006-06-26 | 2019-03-26 | Akebia Therapeutics Inc | Inhibidores de prolil hidroxilasa y métodos de uso |
| WO2009002533A1 (en) * | 2007-06-27 | 2008-12-31 | The Brigham And Women's Hospital, Inc. | Inflammatory bowel disease therapies |
| NO2686520T3 (ko) | 2011-06-06 | 2018-03-17 | ||
| ES2974273T3 (es) | 2013-06-13 | 2024-06-26 | Akebia Therapeutics Inc | Composiciones y métodos para tratar la anemia |
| TWI665190B (zh) | 2013-11-15 | 2019-07-11 | 阿克比治療有限公司 | ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途 |
| WO2016118858A1 (en) | 2015-01-23 | 2016-07-28 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
| HUE056958T2 (hu) | 2015-04-01 | 2022-04-28 | Akebia Therapeutics Inc | Készítmények és eljárások vérszegénység kezelésére |
| CN105130888A (zh) * | 2015-10-09 | 2015-12-09 | 中国药科大学 | 炔基吡啶类脯氨酰羟化酶抑制剂、其制备方法和医药用途 |
| US11713298B2 (en) | 2018-05-09 | 2023-08-01 | Akebia Therapeutics, Inc. | Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0541042A1 (de) * | 1991-11-05 | 1993-05-12 | Hoechst Aktiengesellschaft | Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
| TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-03-25 DE DE4410480A patent/DE4410480A1/de not_active Withdrawn
-
1995
- 1995-03-13 DK DK95103582T patent/DK0673932T3/da active
- 1995-03-13 AT AT95103582T patent/ATE193702T1/de not_active IP Right Cessation
- 1995-03-13 DE DE59508440T patent/DE59508440D1/de not_active Expired - Fee Related
- 1995-03-13 EP EP95103582A patent/EP0673932B1/de not_active Expired - Lifetime
- 1995-03-13 ES ES95103582T patent/ES2146676T3/es not_active Expired - Lifetime
- 1995-03-13 PT PT95103582T patent/PT673932E/pt unknown
- 1995-03-23 CZ CZ1995734A patent/CZ289536B6/cs not_active IP Right Cessation
- 1995-03-23 NZ NZ270784A patent/NZ270784A/en unknown
- 1995-03-23 AU AU15043/95A patent/AU688450B2/en not_active Ceased
- 1995-03-23 FI FI951387A patent/FI951387A/fi unknown
- 1995-03-24 JP JP7065926A patent/JPH07278110A/ja active Pending
- 1995-03-24 PL PL95307847A patent/PL180678B1/pl unknown
- 1995-03-24 NO NO951149A patent/NO304265B1/no not_active IP Right Cessation
- 1995-03-24 HU HU9500864A patent/HUT72598A/hu unknown
- 1995-03-24 US US08/410,610 patent/US5620996A/en not_active Expired - Fee Related
- 1995-03-24 CA CA002145475A patent/CA2145475A1/en not_active Abandoned
- 1995-03-24 ZA ZA952409A patent/ZA952409B/xx unknown
- 1995-03-25 KR KR1019950006805A patent/KR950032126A/ko not_active Application Discontinuation
-
1998
- 1998-12-10 HK HK98113073A patent/HK1011973A1/xx not_active IP Right Cessation
-
2000
- 2000-06-16 GR GR20000401396T patent/GR3033706T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT72598A (en) | 1996-05-28 |
| GR3033706T3 (en) | 2000-10-31 |
| FI951387A0 (fi) | 1995-03-23 |
| NO951149D0 (no) | 1995-03-24 |
| FI951387A (fi) | 1995-09-26 |
| NZ270784A (en) | 1997-02-24 |
| CA2145475A1 (en) | 1995-09-26 |
| EP0673932B1 (de) | 2000-06-07 |
| AU688450B2 (en) | 1998-03-12 |
| PL307847A1 (en) | 1995-10-02 |
| ZA952409B (en) | 1995-11-28 |
| NO304265B1 (no) | 1998-11-23 |
| DE59508440D1 (de) | 2000-07-13 |
| DK0673932T3 (da) | 2000-09-18 |
| EP0673932A1 (de) | 1995-09-27 |
| ES2146676T3 (es) | 2000-08-16 |
| AU1504395A (en) | 1995-10-05 |
| ATE193702T1 (de) | 2000-06-15 |
| KR950032126A (ko) | 1995-12-20 |
| CZ289536B6 (cs) | 2002-02-13 |
| JPH07278110A (ja) | 1995-10-24 |
| US5620996A (en) | 1997-04-15 |
| PT673932E (pt) | 2000-09-29 |
| PL180678B1 (pl) | 2001-03-30 |
| NO951149L (no) | 1995-09-26 |
| CZ73495A3 (en) | 1995-11-15 |
| DE4410480A1 (de) | 1995-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1011973A1 (en) | Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-n-oxides process for their preparation and their use as medicaments | |
| FI951386A (fi) | Sulfanamidokarbonyylipyridiini-2-karboksyylihappoamidit sekä niiden pyridiini-N-oksidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| ATE164846T1 (de) | Neue siliciumhaltige salicylsäurederivate mit abschuppenden eigenschaften | |
| CA2174033A1 (fr) | Nouveaux composes pyridiniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| IL109397A0 (en) | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT49349A (en) | Process for producing substituted 6-phenyldihydro-3-/2h/-pyridazinone derivatives and pharmaceutical compositions comprising such compounds | |
| HU9802645D0 (en) | New metalloproteinase inhibitors, process for producing them, and pharmaceutical compositions containing them | |
| IL119054A0 (en) | Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them | |
| HUT40090A (en) | New process for production of derivatives of hh-1,2,4-triasole | |
| HUT50469A (en) | Process for producing quinolinecarboxylic acids substituted by heterocyclic group | |
| IL115028A0 (en) | Cyclohexadiene derivatives their pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20040313 |
|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |